$9.81
0.41% today
NYSE, Nov 26, 05:52 pm CET
ISIN
US29089Q1058
Symbol
EBS
Sector
Industry

Emergent Biosolutions Inc Target price 2024 - Analyst rating & recommendation

Emergent Biosolutions Inc Classifications & Recommendation:

Buy
67%
Sell
33%

Emergent Biosolutions Inc Price Target

Target Price $14.00
Price $9.85
Potential
Number of Estimates 2
2 Analysts have issued a price target Emergent Biosolutions Inc 2025 . The average Emergent Biosolutions Inc target price is $14.00. This is higher than the current stock price. The highest price target is , the lowest is .
A rating was issued by 3 analysts: 2 Analysts recommend Emergent Biosolutions Inc to buy, 0 to hold and 1 to sell.
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis.
Analyst Estimates: Analysts believe that the Emergent Biosolutions Inc stock has an average upside potential 2025 of . Most analysts recommend the Emergent Biosolutions Inc stock at Purchase.

Sales and Margin forecast 2024, 2025 to 2028

Create a premium account to unlock analyst estimates. Learn more

Quarter Annually
Dec '23 2024
Estimates
Revenue Billion $ 1.05 1.11
6.10% 5.69%
EBITDA Margin -4.09% 8.06%
356.88% 297.14%
Net Margin -76.56% -19.46%
274.77% 74.58%

3 Analysts have issued a sales forecast Emergent Biosolutions Inc 2024 . The average Emergent Biosolutions Inc sales estimate is

$1.1b
Unlock
. This is
1.47% lower
Unlock
than the revenue of the last 12 months(TTM). The highest sales forecast is
$1.1b 0.93%
Unlock
, the lowest is
$1.1b 3.78%
Unlock
.

This results in the following potential growth metrics:

Revenue Estimates

2023 $1.0b 6.10%
2024
$1.1b 5.69%
Unlock
2025
$1.1b 2.16%
Unlock
2026
$1.1b 2.92%
Unlock
2027
$1.2b 5.91%
Unlock
2028
$1.2b 4.37%
Unlock

2 Analysts have issued an Emergent Biosolutions Inc EBITDA forecast 2024. The average Emergent Biosolutions Inc EBITDA estimate is

$89.4m
Unlock
. This is
251.97% higher
Unlock
than the EBITDA of the last 12 months(TTM). The highest EBITDA forecast is
$185m 627.56%
Unlock
, the lowest is
$-6.0m 123.62%
Unlock
.

This results in the following potential growth metrics and future EBITDA Margins:

EBITDA Estimates

2023 $-42.9m 329.00%
2024
$89.4m 308.39%
Unlock
2025
$212m 137.14%
Unlock
2026
$156m 26.64%
Unlock

EBITDA Margin

2023 -4.09% 356.88%
2024
8.06% 297.14%
Unlock
2025
18.71% 132.13%
Unlock
2026
14.14% 24.43%
Unlock

3 Emergent Biosolutions Inc Analysts have issued a net profit forecast 2024. The average Emergent Biosolutions Inc net profit estimate is

$-216m
Unlock
. This is
2.68% higher
Unlock
than the net profit for the last 12 months(TTM). The highest net profit forecast is
$-184m 17.07%
Unlock
, the lowest is
$-275m 23.90%
Unlock
.

This results in the following potential growth metrics and future Net Margins:

Net Profit Estimates

2023 $-803m 251.90%
2024
$-216m 73.13%
Unlock
2025
$18.9m 108.77%
Unlock
2026
$15.1m 20.38%
Unlock
2027
$21.6m 43.50%
Unlock
2028
$32.5m 50.00%
Unlock

Net Margin

2023 -76.56% 274.77%
2024
-19.46% 74.58%
Unlock
2025
1.67% 108.58%
Unlock
2026
1.37% 17.96%
Unlock
2027
1.86% 35.77%
Unlock
2028
2.67% 43.55%
Unlock

Earnings per share, P/E ratio and EV/sales Estimates 2024, 2025 to 2028

Create a premium account to unlock analyst estimates. Learn more

Quarter Annually
Dec '23 2024
Estimates
Earnings Per Share $ -14.85 -3.99
251.90% 73.13%
P/E negative
EV/Sales 0.95

3 Analysts have issued a Emergent Biosolutions Inc forecast for earnings per share. The average Emergent Biosolutions Inc <a href=https://blog.stocksguide.com/knowledge/eps-simply-explained>EPS is

$-3.99
Unlock
. This is
2.68% higher
Unlock
than earnings per share in the financial year 2023. The highest <a href=https://blog.stocksguide.com/knowledge/eps-simply-explained>EPS forecast is
$-3.40 17.07%
Unlock
, the lowest is
$-5.08 23.90%
Unlock
.

This results in the following potential growth metrics and future valuations:

Earnings Per Share

2023 $-14.85 251.90%
2024
$-3.99 73.13%
Unlock
2025
$0.35 108.77%
Unlock
2026
$0.28 20.00%
Unlock
2027
$0.40 42.86%
Unlock
2028
$0.60 50.00%
Unlock

P/E ratio

Current -2.40 1,311.76%
2024
-2.47 2.92%
Unlock
2025
28.14 1,239.27%
Unlock
2026
35.33 25.55%
Unlock
2027
24.63 30.29%
Unlock
2028
16.42 33.33%
Unlock

Based on analysts' sales estimates for 2024, the Emergent Biosolutions Inc stock is valued at an <a href=https://blog.stocksguide.com/knowledge/enterprise-value-sales-simply-explained>EV/Sales of

and an <a href=https://blog.stocksguide.com/knowledge/price-sales-ratio-simply-explained>P/S ratio of .

This results in the following potential growth metrics and future valuations:

EV/Sales

Current 0.94 14.63%
2024
0.95 1.04%
Unlock
2025
0.93 2.12%
Unlock
2026
0.96 3.02%
Unlock
2027
0.90 5.59%
Unlock
2028
0.87 4.19%
Unlock

P/S ratio

Current 0.47 383.38%
2024
0.48 1.50%
Unlock
2025
0.47 2.12%
Unlock
2026
0.49 3.01%
Unlock
2027
0.46 5.58%
Unlock
2028
0.44 4.19%
Unlock

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today